Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia
(NASDAQ: AMLX) Delayed: 16.84 +0.56 (3.44%)
Previous Close $16.28    52 Week High $ 
Open $16.06    52 Week Low $ 
Day High $16.86    P/E N/A 
Day Low $15.71    EPS $ 
Volume 646,988